Bregua Corp - Net Worth and Insider Trading
Bregua Corp Net Worth
The estimated net worth of Bregua Corp is at least $198 Million dollars as of 2024-11-13. Bregua Corp is the 10% Owner of Janux Therapeutics Inc and owns about 3,749,250 shares of Janux Therapeutics Inc (JANX) stock worth over $198 Million. Details can be seen in Bregua Corp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bregua Corp has not made any transactions after 2021-06-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Bregua Corp
Bregua Corp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bregua Corp owns 1 companies in total, including Janux Therapeutics Inc (JANX) .
Click here to see the complete history of Bregua Corp’s form 4 insider trades.
Insider Ownership Summary of Bregua Corp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| JANX | Janux Therapeutics Inc | 2021-06-15 | 10 percent owner |
Bregua Corp Latest Holdings Summary
Bregua Corp currently owns a total of 1 stock. Bregua Corp owns 3,749,250 shares of Janux Therapeutics Inc (JANX) as of June 15, 2021, with a value of $198 Million.
Latest Holdings of Bregua Corp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| JANX | Janux Therapeutics Inc | 2021-06-15 | 3,749,250 | 52.91 | 198,372,818 |
Holding Weightings of Bregua Corp
Bregua Corp Form 4 Trading Tracker
According to the SEC Form 4 filings, Bregua Corp has made a total of 1 transactions in Janux Therapeutics Inc (JANX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Janux Therapeutics Inc is the acquisition of 58,823 shares on June 15, 2021, which cost Bregua Corp around $999,991.
Insider Trading History of Bregua Corp
- 1
Bregua Corp Trading Performance
GuruFocus tracks the stock performance after each of Bregua Corp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bregua Corp is 67.33%. GuruFocus also compares Bregua Corp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bregua Corp within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Bregua Corp's insider trading performs compared to the benchmark.
Performance of Bregua Corp
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 44.19 | | | | | |
| Relative Return to S&P 500(%) | 41.52 | | | | | |
Bregua Corp Ownership Network
Ownership Network List of Bregua Corp
Ownership Network Relation of Bregua Corp
Bregua Corp Owned Company Details
What does Janux Therapeutics Inc do?
Who are the key executives at Janux Therapeutics Inc?
Bregua Corp is the 10 percent owner of Janux Therapeutics Inc. Other key executives at Janux Therapeutics Inc include director & Chief Executive Officer David Alan Campbell , director & 10 percent owner Ra Capital Healthcare Fund Lp , and 10 percent owner Avalon Ventures Xi, L.p. .
Janux Therapeutics Inc (JANX) Insider Trades Summary
Over the past 18 months, Bregua Corp made no insider transaction in Janux Therapeutics Inc (JANX). Other recent insider transactions involving Janux Therapeutics Inc (JANX) include a net sale of 3,324,326 shares made by Avalon Ventures Xi, L.p. , a net sale of 653,961 shares made by Jay Lichter , and a net purchase of 1,695,008 shares made by Ra Capital Healthcare Fund Lp .
In summary, during the past 3 months, insiders sold 2,782,995 shares of Janux Therapeutics Inc (JANX) in total and bought 1,200,000 shares, with a net sale of 1,582,995 shares. During the past 18 months, 6,605,716 shares of Janux Therapeutics Inc (JANX) were sold and 4,244,570 shares were bought by its insiders, resulting in a net sale of 2,361,146 shares.
Janux Therapeutics Inc (JANX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Janux Therapeutics Inc Insider Transactions
Bregua Corp Mailing Address
Above is the net worth, insider trading, and ownership report for Bregua Corp. You might contact Bregua Corp via mailing address: C/o Janux Therapeutics, Inc., 11099 N. Torrey Pines Road, Suite 290, La Jolla Ca 92037.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
